#MPAL MEDPAL AI +10%; Launch of MedPal Health OS, connecting wearable data to AI triage, clinician-led prescribing & robotic dispensing in a single continuous data loop, a platform no other company in the UK provides. Outlook is optimistic.
#MPAL Secondary listing on the Frankfurt Exchange to support their European expansion 👀
Company intends to extend additional MedPal services into Germany, leveraging the country's rapidly growing digital health market which is expected to expand at annual growth rate of 20%
#MPAL, this has been missed. I've flagged a few times. Miss in, miss out. Cheap as chips ATM.
Secondary Listing on Frankfurt Exchange https://t.co/yZ94qF9SjF via @LondonSouthEast
The UK government is investing £82.6 million in cutting-edge AI research, empowering UK scientists to drive breakthroughs in cancer treatment, Alzheimer’s research, and drug discovery.
At MedPal AI (AIM: MPAL), we’re seeing this momentum first-hand. Investors are backing AI platforms that don’t just collect data, but translate it into actionable health outcomes — exactly where our technology is focused.
The signal is clear: the next phase of healthcare innovation will be powered by AI that delivers measurable results.
https://t.co/dS2DQNJKaL #MPAL
This is a game changer for the industry by making workflows resilient, adaptive and intelligently coordinated.
Read more: https://t.co/01psivgPlx #MPAL#AINews#AIHealthcare